Five frequent polymorphisms of the PAI-1 gene: Lack of association between genotypes, PAI activity, and triglyceride levels in a healthy population

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 5, 1997, Pages 851-858

  Henry, Mireille ^a   Chomiki, Nathalie ^a   Scarabin, Pierre Yves ^a   Alessi, Marie Christine ^a   Peiretti, Franck ^a   Arveiler, Dominique ^b   Ferrières, Jean ^b   Evans, Alun ^c   Amouyel, Philippe ^d   Poirier, Odette ^a   Cambien, François ^a   Juhan Vague, Irène ^a,e  

^a INSERM   (France)

^b MONICA Project   (France)

^c MONICA Project   (United Kingdom)

^d MONICA Project   (France)

^e TIMONE HOSPITAL   (France)

Author keywords

healthy subjects; metabolic parameters; PAI activity; PAI 1; PCR SSCP polymorphism

Indexed keywords

DNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; ADULT; ARTICLE; DNA SEQUENCE; EUROPE; FIBRINOLYSIS; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 16944367480     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.5.851     Document Type: Article

References (16)

1. Ginsburg D, Zeheb R, Yang AY, Rafferty UM, Andreasen PA, Nielsen L, Dano K, Lebo R, Gelehrter TD. cDNA cloning of human plasminogen activalor-inhibitor from endothelial cells. J Clin Invest. 1986;78:1673-1680.
2. Ny T, Sawdey M, Lawrence D, Millan JL, Loskutoff DJ. Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci U S A. 1986;83:6776-6780.
3. Pannekoek H, Veerman H, Lambers H, Diergarde P, Verweij CL, Van Zonneveld AJ, Van Mourik JA. Endothelial plasminogen activator inhibitor (PAI): a new member of the Serpin gene family. EMBO J. 1986;5:2539-2544.
4. Kruithof EKO, Tran-Thang C, Ransijn A, Bachmann F. Demonstration of the fast-acting inhibitor of plasminogen activators in human plasma. Blood. 1984;64:907-913.
5. Thorsen S, Philips M, Selmer J, Lecander I, Astedt B. Kinetics of inhibition of tissue-type and urokinase-type plasminogen. Eur J Biochem. 1988;175:33-39.
6. Juhan-Vague I, Alessi MC. Plasminogen activator inhibitor-1 and atherothrombosis. Thromb Haemost. 1993;70:138-143.
7. Hamsten A, de Faire U, Walldius G, Dahlen G, Szamosi A, Landou C, Blombäck M. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet. 1987;2:3-9.
8. Van de Loo JCW, Haverkate F, Thompson SA. Haemostatic factor and the risk of myocardial infarction. N Engl J Med. 1995;332:389-390.
9. Salomaa V, Stinson V, Kark JD, Folsom AR, Davis CE, Wu KK. Association of fibrinolytic parameters with early atherosclerosis: the ARIC study. Circulation. 1995;91:284-290.
10. Juhan-Vague I, Alessi MC, Joly P, Thirion X, Vague P, Declerck PJ, Serradimigni A, Collen D. Plasma plasminogen activator inhibitor-1 in angina pectoris: influence of insulin and acute phase response. Arteriosclerosis. 1989;9:362-367.
11. Mansfield MW, Strickland MH, Carter AM, Grant PJ. Polymorphisms of the plasminogen activator inhibitor-1 gene in type 1 and type 2 diabetes, and in patients with diabetic retinopathy. Thromb Haemost. 1994;71:731-736.
12. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S. Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. Arterioscler Thromb. 1991;11:183-190.
13. Klinger KW, Winqvist R, Riccio A, Andreasen PA, Sartorio R, Nielsen LS, Stuart N, Stanislovitis P, Watkins P, Douglas R, Grzeschik KH, Alitalo K. Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis. Proc Natl Acad Sci U S A. 1991;84:8548-8552.
14. Dawson S, Wiman B, Hamsten A, Green F, Humphries S, Henney AM. The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-I (PAI-1) gene respond differently to interleukin-1 in HepG2 cells. J Biol Chem. 1993;268:10739-10745.
15. Eriksson P, Kallin B, van't Hooft FM, Bavenholm P, Hamsten A. Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci U S A. 1995;92:1851-1855.
16. Ye S, Green FR, Scarabin PY, Nicaud V, Bara L, Dawson SJ, Humphries SE, Evans A, Luc G, Cambou JP, Arveiler D, Henney AM, Cambien F. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Thromb Haemost. 1995;74:837-841.